Concepedia

Rachel Dobson

RD

Statistics

Publications

14

Citations

712

H-Index

13

Active since

2005

Affiliations

University of Cambridge(Current)

Cambridge University Hospitals NHS Foundation Trust

University of Southampton

Cancer Research UK

Royal Marsden Hospital

Rachel Dobson is an author at University of Cambridge specializing in oncology, medicine, and molecular oncology.

Publications per year

2005–2023

14

Publications

14

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit

Francesco Cucco, Sharon Barrans, Chulin Sha et al. · Leukemia · 2019 · 117 citations · Full text

, , +17

Fluorescence studies of the intra-cellular distribution of zinc bis(thiosemicarbazone) complexes in human cancer cells

A.R. Cowley, Jason J. Davis, Jonathan R. Dilworth et al. · Chemical Communications · 2005 · 111 citations

, , +12

The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1

Marta Larráyoz, Stuart J. Blakemore, Rachel Dobson et al. · Leukemia · 2015 · 103 citations · Full text

, , +14

IL-4 enhances expression and function of surface IgM in CLL cells

Montserrat Aguilar-Hernández, Matthew D. Blunt, Rachel Dobson et al. · Blood · 2016 · 91 citations · Full text

, , +13

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia

Matthew D. Blunt, Stefan Koehrer, Rachel Dobson et al. · Clinical Cancer Research · 2016 · 64 citations · Full text

, , +14

1–5 of 14